Onco-Innovations Ltd. (ONCO) Price & Analysis

21 Followers

ONCO Stock Chart & Stats

C$1.47

C$0.00(0.00%)

At close: Jul 24 4:00 PM EDT

C$1.47

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$1.45 - C$1.53

Previous CloseN/A

Volume0.00

Average Volume (3M)47.16K

Market Cap

C$87.82M

Enterprise ValueC$86.79

Total Cash (Recent Filing)C$1.41M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta0.66

Next Earnings

Sep 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding59,739,610

10 Day Avg. Volume42,021

30 Day Avg. Volume47,156

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Onco-Innovations Ltd. News

BlackRock Adjusts Stake in Caledonia Mining, Triggers Major Holding Disclosure

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an update. Caledonia Mining Corporation Plc has disclosed that asset manager...

16d ago

Onco-Innovations Sets Up Australian Subsidiary and Taps New Marketing Partner Ahead of Phase I Trials

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an announcement. Onco-Innovations has executed an engagement agreement with RDI Partners...

4M ago

Onco-Innovations Raises $1.22 Million in Completed Private Placement

The latest update is out from Onco-Innovations Ltd. ( ($TSE:ONCO) ). Onco-Innovations Limited has closed a non-brokered private...

5M ago

Onco-Innovations Seeks Up to $2 Million in Private Placement to Advance Cancer Research

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations Limited plans to raise up to $2 million...

5M ago

Onco-Innovations Revises Pricing on $2 Million Private Placement

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations has amended the pricing of its previously announced...

6M ago

Onco-Innovations Files Preliminary Base Shelf Prospectus to Boost Financing Flexibility

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an announcement. Onco-Innovations Limited has filed a preliminary base shelf prospectus...

6M ago

Onco-Innovations Leads Precision Oncology Forum to Shape Future Cancer Care

The latest announcement is out from Onco-Innovations Ltd. ( ($TSE:ONCO) ). Onco-Innovations Limited, through its subsidiary Inka Health...

8M ago

Onco-Innovations Explores Nasdaq Cross-Listing and Equity Offering

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an announcement. Onco-Innovations Limited has engaged a U.S. investment bank to...

8M ago

Onco-Innovations Joins University of Alberta’s Innovation Awards, Advances Cancer Treatment Technology

An update from Onco-Innovations Ltd. ( ($TSE:ONCO) ) is now available. Onco-Innovations Limited attended the University of Alberta’s...

8M ago

Onco-Innovations Advances PNKP Inhibitor Technology with Dalton Pharma Services

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has shared an announcement. Onco-Innovations Limited has announced the advancement of its PNKP...

8M ago

ONCO FAQ

What was Onco-Innovations Ltd.’s price range in the past 12 months?

Onco-Innovations Ltd. lowest stock price was C$1.45 and its highest was C$1.53 in the past 12 months.

What is Onco-Innovations Ltd.’s market cap?

Onco-Innovations Ltd.’s market cap is C$87.82M.

When is Onco-Innovations Ltd.’s upcoming earnings report date?

Onco-Innovations Ltd.’s upcoming earnings report date is Sep 11, 2026 which is in 41 days.

How were Onco-Innovations Ltd.’s earnings last quarter?

Onco-Innovations Ltd. released its earnings results on Jul 27, 2026. The company reported -C$0.025 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Onco-Innovations Ltd. overvalued?

According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Onco-Innovations Ltd. pay dividends?

Onco-Innovations Ltd. does not currently pay dividends.

What is Onco-Innovations Ltd.’s EPS estimate?

Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Onco-Innovations Ltd. have?

Onco-Innovations Ltd. has 59,739,610 shares outstanding.

What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?

Onco-Innovations Ltd. reported an EPS of -C$0.025 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Onco-Innovations Ltd.?

Currently, no hedge funds are holding shares in TSE:ONCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Onco-Innovations Ltd. Stock Smart Score

Neutral

Insider Transactions

Sold Shares

Worth C$11.2K over
the Last 3 Months

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-43.87%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Onco-Innovations Ltd.

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.